Drug Safety Matters

#10 Tailoring drug therapy to your genes – Qun-Ying Yue

July 29, 2021
Drug Safety Matters
#10 Tailoring drug therapy to your genes – Qun-Ying Yue
Show Notes

Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.

Tune in to find out:

  • How genetic biomarkers can guide medicine use and dosing recommendations
  • What we need to effectively implement genetic-based prescribing in clinical practice
  • How increasing diversity in clinical trials can aid pharmacogenomics research 

Want to know more?

Here are a few resources to get you started:

Join the conversation on social media
Follow us on Twitter, Facebook or LinkedIn, and share your thoughts about the show with the hashtag #DrugSafetyMatters.

Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!

About UMC
Read more about Uppsala Monitoring Centre and how we work to make medicines safer for patients.